The DoD SBIR/STTR programs prioritize topics that address key defense challenges, including emerging technologies in areas such as: Advanced materials Artificial intelligence and machine learning Cybersecurity Energy Solutions Sensors and Surveillance Space technologies Why Start Early
For Research Use Only (RUO)
Growthhormone receptor interaction BPC-157 interacts with growth hormone receptors, vital for repairing and building tissues in your body
The complete list of substances being removed from Category 2 is as follows: BPC-157 Cathelicidin LL-37 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) KPV Mechano Growth Factor, Pegylated (PEG-MGF) Melanotan II MOTs-C Semax (heptapeptide) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) Of these, the substances not scheduled for consideration at the upcoming meeting in July (Cathelicidin LL-37, Dihexa Acetate, GHK-Cu (injectable routes of administration), Mechano Growth Factor Pegylated (PEG-MGF), and Melanotan II) are slated for separate PCAC consultation before the end of February 2027
The only published human data are from 12 patients with interstitial cystitis (2024) and 2 healthy subjects (2026)
